HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael J Lipinski Selected Research

Ischemia

10/2019Efficacy and Safety of Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin, Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization of Patients With Diabetes Mellitus.
3/2016Multimodality imaging demonstrates trafficking of liposomes preferentially to ischemic myocardium.
2/2016Active Versus Passive Anchoring Vascular Closure Devices Following Percutaneous Coronary Intervention: A Safety and Efficacy Comparative Analysis.
4/2014Molecule 16673-34-0: a new tool in our arsenal against inflammation.
8/2013Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael J Lipinski Research Topics

Disease

18Myocardial Infarction
10/2019 - 01/2006
16Thrombosis (Thrombus)
10/2019 - 09/2008
15Heart Failure
11/2022 - 01/2006
9Hemorrhage
10/2017 - 07/2014
8Acute Coronary Syndrome
10/2017 - 01/2006
8Atherosclerosis
12/2012 - 09/2006
7Coronary Artery Disease (Coronary Atherosclerosis)
02/2016 - 10/2004
6Inflammation (Inflammations)
03/2019 - 04/2007
5ST Elevation Myocardial Infarction
11/2022 - 07/2014
5Ischemia
10/2019 - 08/2013
5Aortic Valve Stenosis (Aortic Stenosis)
01/2018 - 01/2016
5Infarction (Infarctions)
05/2017 - 06/2007
5Left Ventricular Dysfunction
09/2008 - 01/2006
3Diabetes Mellitus
10/2019 - 09/2014
3Stroke (Strokes)
01/2018 - 02/2016
3Cardiovascular Diseases (Cardiovascular Disease)
03/2017 - 09/2014
3Cardiomyopathies (Cardiomyopathy)
01/2017 - 03/2014
2Infections
11/2022 - 01/2020
2Injection Site Reaction
11/2022 - 01/2020
2Stable Angina
01/2018 - 01/2016
2Chronic Limb-Threatening Ischemia
09/2016 - 04/2016
2Atrial Fibrillation
02/2016 - 01/2016
2Pathologic Constriction (Stenosis)
11/2015 - 05/2015
2Atherosclerotic Plaque (Atheroma)
01/2013 - 11/2004
1Neoplasms (Cancer)
10/2017
1Low Cardiac Output
07/2016
1Acute Kidney Injury (Acute Renal Failure)
07/2016
1Hyperlipidemias (Hyperlipidemia)
03/2016
1Compartment Syndromes
03/2016
1Ischemic Stroke
02/2016
1Hemorrhagic Stroke
02/2016
1Angina Pectoris
02/2016
1Hypertension (High Blood Pressure)
02/2016
1Chronic Renal Insufficiency
02/2016
1Hematoma
02/2016
1Vascular System Injuries
02/2016
1False Aneurysm (Pseudoaneurysm)
02/2016
1Arteriovenous Fistula
02/2016
1Coronary Stenosis (Coronary Artery Stenosis)
11/2015
1Chest Pain (Chest Pains)
01/2015
1Anemia
01/2015

Drug/Important Bio-Agent (IBA)

6omega-Chloroacetophenone (Mace)IBA
04/2018 - 11/2007
5GadoliniumIBA
03/2016 - 09/2006
4Hemoglobins (Hemoglobin)IBA
10/2017 - 12/2009
4bivalirudin (Angiomax)FDA Link
12/2016 - 07/2014
4LipidsIBA
03/2016 - 01/2007
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2015 - 01/2006
4Contrast MediaIBA
01/2007 - 11/2004
3Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
11/2022 - 08/2018
3Interleukin-1 (Interleukin 1)IBA
11/2022 - 08/2018
3PolymersIBA
10/2019 - 05/2014
3EverolimusFDA Link
10/2019 - 09/2014
3MetalsIBA
03/2019 - 05/2014
3TicagrelorIBA
01/2018 - 03/2015
3Clopidogrel (Plavix)FDA Link
03/2017 - 08/2014
3Apolipoproteins E (ApoE)IBA
01/2012 - 09/2006
2Heparin (Liquaemin)FDA LinkGeneric
12/2016 - 09/2014
2oxidized low density lipoproteinIBA
02/2016 - 01/2007
2Prasugrel HydrochlorideFDA Link
03/2015 - 08/2014
2Scavenger Receptors (Scavenger Receptor)IBA
05/2009 - 09/2006
1C-Reactive ProteinIBA
01/2020
1Sirolimus (Rapamycin)FDA Link
10/2019
1Fluorocarbon PolymersIBA
03/2019
1CytokinesIBA
08/2018
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
08/2018
1BESIBA
01/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018
1GlucocorticoidsIBA
10/2017
1CreatinineIBA
10/2017
1triphenyltetrazoliumIBA
05/2017
1cangrelorIBA
03/2017
1Simendan (Levosimendan)IBA
07/2016
1Liposomes (Liposome)IBA
03/2016
1AnticoagulantsIBA
02/2016
1CoagulantsIBA
02/2016
1N(4)-oleylcytosine arabinosideIBA
02/2016
1Warfarin (Coumadin)FDA LinkGeneric
02/2016
1CholesterolIBA
02/2016
1ThrombinFDA Link
02/2016
1Glycoproteins (Glycoprotein)IBA
02/2016
1Biomarkers (Surrogate Marker)IBA
01/2016
1Cytidine Triphosphate (CTP)IBA
11/2015
1Phenobarbital (Luminal)FDA Link
05/2015
1TroponinIBA
01/2015
1trans-crotonin (CTN)IBA
01/2015

Therapy/Procedure

20Stents
10/2019 - 01/2006
16Percutaneous Coronary Intervention
10/2019 - 10/2004
14Therapeutics
01/2017 - 01/2006
8Drug-Eluting Stents
10/2019 - 09/2008
5Transcatheter Aortic Valve Replacement
01/2018 - 01/2016
3Coronary Artery Bypass (Coronary Artery Bypass Surgery)
03/2016 - 01/2016
1Injections
01/2018
1Aftercare (After-Treatment)
04/2017
1Intravenous Administration
01/2017
1Length of Stay
07/2016
1Artificial Respiration (Mechanical Ventilation)
07/2016
1Intravenous Injections
03/2016
1Prostheses and Implants (Prosthesis)
03/2016
1Fasciotomy
03/2016
1Blood Transfusion (Blood Transfusions)
01/2015